HIVST uptake in Targeted arm
In the Targeted arm, 1384 (63.5%) accepted HIVST for partner HIV testing (Table Participant characteristics by HIV self‐test acceptance and self‐test use in Targeted arm among women with male partnersAbbreviation: HIVST, HIV self‐test.Among participants whose partners used HIVST.Three separate models were run for partner HIV status (positive vs. not positive, negative vs. not negative and unknown vs. not unknown).Participant risk and partner status knowledge at 9 months postpartum0.93 (0.42–2.03)
0.78 (0.40–1.51)
0.99 (0.87–1.13)
0.97 (0.86–1.08)
1.25 (0.76–2.06)
1.25 (0.76–2.06)
1.03 (0.59–1.81)
0.85 (0.55–1.31)
1.03 (0.85–1.25)
1.09 (0.93–1.29)
Abbreviation: ART, antiretroviral therapy.Adjustment factors include marital status and baseline HIV risk status.Among participants with a partner at 9 months postpartum.Among participants with an unknown partner HIV status and high risk score at enrolment.Among 157 women who initiated PrEP and reported a partner of unknown HIV status at baseline, 114 (72.6%) accepted HIVST for partner testing and 79 (69.3%) subsequently reported their partner was HIV negative. Of these 79 women (PrEP initiators with previously unknown partner HIV status but now known HIV‐negative partner), 49 (62.0%) discontinued PrEP following partner HIVST results. Of the 15 women whose partner was newly determined to be HIV positive or indeterminate, five (33%) had initiated PrEP prior to HIVST results and five (33%) elected to start PrEP after HIVST results, and five (33%) did not start PrEP. Because the NASCOP implemented HIVST in MCH over the course of the study, we ascertained HIVST acceptance in both study arms. However, few women in the Universal arm (0.93%, [21/2250]) reported accepting HIVST through MCH due to stockouts, lack of systematic offer and low awareness.